一般外科

1. Hsu YC, Lee JJ, Chien MN, Chen MJ, Leung CH, Cheng SP. Is papillary thyroid microcarcinoma a biologically different disease? A propensity score-matched analysis. J Surg Oncol. 2019 Nov;120(6):1023-1030. doi: 10.1002/jso.25670. 2. Huang TS, Lee JJ, Li YS, Cheng SP. Ethacridine Induces Apoptosis and Differentiation in Thyroid Cancer Cells In Vitro. Anticancer Res. 2019 Aug;39(8):4095-4100. doi: 10.21873/anticanres.13567. 3. Ko WC, Liu CL, Lee JJ, Liu TP, Wu CJ, Cheng SP. Osteocalcin is an Independent Predictor for Hungry Bone Syndrome After Parathyroidectomy. World J Surg. 2019 Oct 28. doi: 10.1007/s00268-019-05251-0. 4. Liu CL, Hsu YC, Lee JJ, Chen MJ, Lin CH, Huang SY, Cheng SP. Targeting the pentose phosphate pathway increases reactive oxygen species and induces apoptosis in thyroid cancer cells. Mol Cell Endocrinol. 2020 Jan 1;499:110595. doi: 10.1016/j.mce.2019.110595. 5.Chu TP, Yang PS, Lee JJ, Wu CJ, Cheng SP. Increasing Age Hinders the Decline in B-Type Natriuretic Peptide Following Parathyroidectomy in Dialysis Patients. In Vivo. 2019 Sep-Oct;33(5):1691-1696. doi: 10.21873/invivo.11657 6. Lee JJ, Wang TY, Liu CL, Chien MN, Chen MJ, Hsu YC, Leung CH, Cheng SP. Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma. J Clin Endocrinol Metab. 2017 Aug 1;102(8):2930-2940. doi: 10.1210 7. Lee F, Lee JJ, Jan WC, Wu CJ, Chen HH, Cheng SP. Molecular pathways associated with transcriptional alterations in hyperparathyroidism. Oncol Lett. 2016 Jul;12(1):621-626. 8. Cheng SP, Lee JJ, Liu TP, Yang PS, Liu SC, Hsu YC, Liu CL. Quality of Life After Surgery or Surveillance for Asymptomatic Primary Hyperparathyroidism: A Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore). 2015 Jun;94(23):e931. doi: 10.1097/MD.0000000000000931.